ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm

News provided by

Jul 18, 2017, 14:32 ET

NEW YORK, July 18, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at AngioDynamics, Inc. ("AngioDynamics" or the "Company") (NASDAQ: ANGO).

The investigation focuses on whether the Company and its executives violated federal securities laws. Specifically, after market on July 17, 2017, the Company filed a Form 8-K with the Securities and Exchange Commission disclosing, among other things, that its former independent registered public accounting firm has "determined that there was a material weakness in the Company's internal control over financial reporting as of May 31, 2016 because the Company did not design and maintain effective internal controls over the accounting for the annual goodwill impairment test."

On this news, the Company's share price declined, causing harm to investors.

If you invested in AngioDynamics stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/ANGO. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26^th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP